AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2024
Jun 17, 2024
32464_dirs_2024-06-17_de7d950e-ec6a-467a-9acf-ddab0d7a8274.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2024-06-14
Reporting Person: Donhauser Peter D.O. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-14 | Common Stock | P | 2835 | $3.64 | Acquired | 5000 | Direct |
Footnotes
F1: Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.936
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25